Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
14-day Bismuth Quadruple vs 7-day Tailored Therapy for H. pylori Eradication
NCT02359331Terminated
- Sponsor
- Seoul National University Bundang Hospital
- Start
- Aug 2014
- Primary completion
- Dec 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of moxifloxacin and amoxicillin in Helicobacter pylori infection (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoint: Helicobacter pylori eradication rate at 6 weeks. Started Aug 2014; status: terminated.
02
Drugs
moxifloxacinamoxicillin
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02359331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02359331.